Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 September 2021 | Story Michelle Nöthling | Photo Supplied
Peet Jacobs.

Peet Jacobs is no stranger to the Deaf community in and around the UFS and Bloemfontein. He has been working at the University of the Free State (UFS) for the past six years, and he is still amazed at the amount of support our institution provides to Deaf students in particular, and to South African Sign Language (SASL) in general. “They provide excellent interpreting services,” Peet says, “not only in face-to-face classes, but also on different online platforms, as well as interpreting pre-recorded lectures and videos.” And as a SASL interpreter, Peet is an integral part of this service. 

But signing is not merely a day job for Peet. He carries his skill into the community in his spare time, where he assists as an interpreter at hospitals, doctors’ rooms, and psychiatrists’ offices – to name but a few. What gives Peet the deepest satisfaction, however, is when he can combine his love of Sign Language with his love of the Bible and his God. It was actually Peet’s devotion to his religion that inspired him to learn Sign Language in order to enable him to carry the Word of God into the Deaf community. Peet now also presents Bible courses in SASL and assists a non-profit organisation to produce SASL Bible-based publications, which are translated and recorded in video format. 

Peet aspires to become an authority on SASL subject-specific vocabulary related to subject in higher education. “Sign Language is a language in its own right,” Peet points out. “The uniqueness of Deaf culture and the variety of dialects within SASL give the language diversity and colour.” Peet goes on to emphasise how important it is that SASL is recognised as an official language in our country. “This recognition will give dignity to a group of people who have been marginalised in South Africa. This will also pave the way to providing more inclusivity and service to the Deaf community.”

Until then, Peet will continue to serve the best way he knows how: through signing.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept